- Home
- PFX vs XTNT Comparison
PFX vs XTNT Comparison
Compare PFX & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFX
- XTNT
- Stock Information
- Founded
- PFX 2010
- XTNT N/A
- Country
- PFX United States
- XTNT United States
- Employees
- PFX N/A
- XTNT N/A
- Industry
- PFX Finance: Consumer Services
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PFX Finance
- XTNT Health Care
- Exchange
- PFX Nasdaq
- XTNT Nasdaq
- Market Cap
- PFX 94.7M
- XTNT 100.0M
- IPO Year
- PFX N/A
- XTNT N/A
- Fundamental
- Price
- PFX $47.83
- XTNT $0.58
- Analyst Decision
- PFX
- XTNT Strong Buy
- Analyst Count
- PFX 0
- XTNT 1
- Target Price
- PFX N/A
- XTNT $3.00
- AVG Volume (30 Days)
- PFX 1.1K
- XTNT 60.2K
- Earning Date
- PFX 08-06-2024
- XTNT 11-07-2024
- Dividend Yield
- PFX N/A
- XTNT N/A
- EPS Growth
- PFX 36.92
- XTNT N/A
- EPS
- PFX 9.66
- XTNT N/A
- Revenue
- PFX $22,293,269.00
- XTNT $110,943,000.00
- Revenue This Year
- PFX $19.50
- XTNT $32.72
- Revenue Next Year
- PFX $9.74
- XTNT $18.34
- P/E Ratio
- PFX $4.95
- XTNT N/A
- Revenue Growth
- PFX 14.03
- XTNT 63.37
- 52 Week Low
- PFX $36.38
- XTNT $0.51
- 52 Week High
- PFX $48.55
- XTNT $1.45
- Technical
- Relative Strength Index (RSI)
- PFX 53.84
- XTNT 42.51
- Support Level
- PFX $47.28
- XTNT $0.53
- Resistance Level
- PFX $48.55
- XTNT $0.62
- Average True Range (ATR)
- PFX 0.26
- XTNT 0.03
- MACD
- PFX 0.03
- XTNT -0.01
- Stochastic Oscillator
- PFX 53.55
- XTNT 36.00
About PFX PhenixFIN Corporation
PhenixFIN Corp formerly Medley Capital Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.